Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial

Michelle Sholzberg; Grace H Tang; Hassan Rahhal; Musaad AlHamzah; Lisa Baumann Kreuziger; Fionnuala Ní Áinle; Faris Alomran; Khalid Alayed; Mohammed Alsheef; Fahad AlSumait; Carlos Eduardo Pompilio; Catherine Sperlich; Sabrena Tangri; Terence Tang; Peter Jaksa; Deepa Suryanarayan; Mozah Almarshoodi; Lana A Castellucci; Paula D James; David Lillicrap; Marc Carrier; Andrew Beckett; Christos Colovos; Jai Jayakar; Marie-Pier Arsenault; Cynthia Wu; Karine Doyon; E Roseann Andreou; Vera Dounaevskaia; Eric K Tseng; Gloria Lim; Michael Fralick; Saskia Middeldorp; Agnes Y Y Lee; Fei Zuo; Bruno R da Costa; Kevin E Thorpe; Elnara Márcia Negri; Mary Cushman; Peter Jüni

BMJ (2021) - Comments
pubmed: 34649864 doi: 10.1136/bmj.n2400 issn: 1756-1833

Michelle Sholzberg, Grace H Tang, Hassan Rahhal, Musaad AlHamzah, Lisa Baumann Kreuziger, Fionnuala Ní Áinle, Faris Alomran, Khalid Alayed, Mohammed Alsheef, Fahad AlSumait, Carlos Eduardo Pompilio, Catherine Sperlich, Sabrena Tangri, Terence Tang, Peter Jaksa, Deepa Suryanarayan, Mozah Almarshoodi, Lana A Castellucci, Paula D James, David Lillicrap